Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...
As the year comes to a close, the overall level of global mergers and acquisitions activity in 2024 is expected to be $3.5 ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Loomis Sayles, an investment management company, released its “International Growth Fund” third quarter 2024 investor letter.
Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.
Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...
In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...
EUROPE’S Stoxx 600 index clocked its first weekly advance in three on Friday (Dec 27), boosted by advancing healthcare and ...
From politics to pop culture, climate to conflict, 2024 was a year of tumbling records … but not always for the best reasons.
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...
INR:3385. members of zerobaseone Innovent Biologics' Phase 3 clinical trial of Sintilimab as first-line treatment for advanced liver cancer reaches primary ...
Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, says he was close to the departure lounge when it was hit. Ukraine's air force says it detected 184 missiles and ...